Skip to main content

Advertisement

SpringerLink
Log in

Retinol-binding protein-4 and hs-CRP levels in patients with migraine

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Retinol-binding protein-4 (RBP4) and high-sensitivity C-reactive protein (hs-CRP) levels are associated with inflammation in patients with migraine. The release of proinflammatory cytokines during migraine results in recurrent sterile neurogenic inflammation. This study aimed to determine the correlation between RBP4 and hs-CRP levels, and migraine, which is considered an inflammatory disease. The study included 48 migraine patients and 40 age- and gender-matched controls. Migraine was diagnosed according to International Classification of Headache Disorders-II. The serum RBP4 level was measured using a commercial ELISA kit and hs-CRP was measured using an enzyme immunoassay test kit. The serum RBP4 level was significantly lower in the migraine patients than in the controls (P < 0.001), whereas the hs-CRP level was significantly higher in the migraine patients (P < 0.001). RBP4 and hs-CRP levels did not differ between the migraine patients with and without aura (P > 0.05). Migraine headache severity, frequency and duration were not correlated with serum RBP or hs-CRP levels (P > 0.05). The observed high hs-CRP level and low RBP4 level in migraine patients suggest that vitamin A might play a major role in the pathogenesis of migraine. It is known that inflammation is a key factor in many diseases. Additional research might result in a better understanding of the anti-inflammatory effects of vitamin A.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tzourio C, Tehindrazanarivelo A, Iglésias S, Alpérovitch A, Chedru F, d’Anglejan-Chatillon J, Bousser MG (1995) Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 310:830–833

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Hamel E (2007) Serotonin and migraine: biology and clinical implications. Cephalalgia 27:1293–1300

    Article  CAS  PubMed  Google Scholar 

  3. Moskowitz MA (1984) The neurobiology of vascular head pain. Ann Neurol 16:157–168

    Article  CAS  PubMed  Google Scholar 

  4. Perini F, D’Andrea G, Galloni E et al (2005) Plasma cytokine levels in migraineurs and controls. Headache 45:926–931

    Article  PubMed  Google Scholar 

  5. Boćkowski L, Sobaniec W, Zelazowska-Rutkowska B (2009) Proinflammatory plasma cytokines in children with migraine. Pediatr Neurol 41:17–21

    Article  PubMed  Google Scholar 

  6. Güzel I, Taşdemir N, Celik Y (2013) Evaluation of serum transforming growth factor β1 and C-reactive protein levels in migraine patients. Neurol Neurochir Pol 47:357–362

    PubMed  Google Scholar 

  7. Vanmolkot FH, de Hoon JN (2007) Increased C-reactive protein in young adult patients with migraine. Cephalalgia 27:843–846

    Article  CAS  PubMed  Google Scholar 

  8. Mora JR, Iwata M, von Andrian UH (2008) Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 8:685–698

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Wang Y, Connors R, Fan P et al (2014) Structure-assisted discovery of the first non-retinoid ligands for retinol-binding protein 4. Bioorg Med Chem Lett 24:2885–2891

    Article  CAS  PubMed  Google Scholar 

  10. Zhong M, Kawaguchi R, Ter-Stepanian M et al (2013) Vitamin A transport and the transmembrane pore in the cell-surface receptor for plasma retinol binding protein. PLoS One 18(11):e73838. doi:10.1371/journal.pone.0073838

    Article  Google Scholar 

  11. Engle-Stone R, Haskell MJ, Nankap M, Ndjebayi AO, Brown KH (2014) pRBP provide similar estimates of vitamin A deficiency prevalence. J Nutr 144:209–217

    Article  CAS  PubMed  Google Scholar 

  12. Xiao Y, Xu A, Hui X et al (2013) Circulating lipocalin-2 and retinol-binding protein 4 are associated with intima-media thickness and subclinical atherosclerosis in patients with type 2 diabetes. PLoS One 8(6):e66607. doi:10.1371/journal.pone.0066607 (Print 2013)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Mohapatra J, Sharma M, Acharya A et al (2011) Retinol-binding protein 4: a possible role in cardiovascular complications. Br J Pharmacol 164:1939–1948

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Yang Q, Graham TE, Mody N et al (2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436:356–362

    Article  CAS  PubMed  Google Scholar 

  15. Rosales FJ, Ritter SJ, Zolfaghari R et al (1996) Effects of acute inflammation on plasma retinol, retinol-binding protein, and its mRNA in the liver and kidneys of vitamin A-sufficient rats. J Lipid Res 37:962–971

    CAS  PubMed  Google Scholar 

  16. Baeten JM, Richardson BA, Bankson DD et al (2004) Use of serum retinol-binding protein for prediction of vitamin A deficiency: effects of HIV-1 infection, protein malnutrition, and the acute phase response. Am J Clin Nutr 79:218–225

    CAS  PubMed  Google Scholar 

  17. Calò LA, Maiolino G, Pagnin E, Vertolli U, Davis PA (2014) Increased RBP4 in a human model of activated anti-atherosclerotic and antiremodeling defences. Eur J Clin Invest 44:567–572

    Article  PubMed  Google Scholar 

  18. Torelli P, Beghi E, Manzoni GC (2004) Appendix to the international classification of headache disorders (2nd edition): application of diagnostic criteria for tension-type headache. Cephalalgia 24:791

    Article  Google Scholar 

  19. Azapağasi E, Alehan F, Saygi S, Bayraktar N, Yazici AC (2012) Serum concentrations of neuron-specific enolase in pediatric migraine. Turk J Pediatr 54:150–155

    PubMed  Google Scholar 

  20. WHO Expert Committee (1995) Physical status: the use and interpretation of anthropometry. WHO Technical Report Series No. 854. WHO, Geneva

    Google Scholar 

  21. Engedal N (2011) Immune regulator vitamin A and T cell death. Vitam Horm 86:153–178

    Article  CAS  PubMed  Google Scholar 

  22. Kim CH (2011) Retinoic acid, immunity, and inflammation. Vitam Horm 86:83–101

    Article  CAS  PubMed  Google Scholar 

  23. World Health Organization (1996) Indicators for assessing vitamin A deficiency and their application in monitoring and evaluating intervention programmes. World Health Organization, Geneva

    Google Scholar 

  24. Graham TE, Wason CJ, Blüher M, Kahn BB (2007) Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects. Diabetologia 50:814–823

    Article  CAS  PubMed  Google Scholar 

  25. Baeten JM, Richardson BA, Bankson DD et al (2004) Use of serum retinol-binding protein for prediction of vitamin A deficiency: effects of HIV-1 infection, protein malnutrition, and the acute phase response. Am J Clin Nutr 79:218–225

    CAS  PubMed  Google Scholar 

  26. Almekinder J, Manda W, Soko D, Lan Y, Hoover DR, Semba RD (2000) Evaluation of plasma retinol-binding protein as a surrogate measure for plasma retinol concentrations. Scand J Clin Lab Invest 60:199–203

    Article  CAS  PubMed  Google Scholar 

  27. Yasunari K, Maeda K, Nakamura M, Yoshikawa J (2002) Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and C-reacting protein. Hypertension 39:777–780

    Article  CAS  PubMed  Google Scholar 

  28. Lowe GD, Pepys MB (2006) C-reactive protein and cardiovascular disease: weighing the evidence. Curr Atheroscler Rep 8:421–428

    Article  CAS  PubMed  Google Scholar 

  29. Welch KM, Brandes AW, Salerno L, Brandes JL (2006) C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache. 46:197–199

    Article  CAS  PubMed  Google Scholar 

  30. Meng WG, Shi L, Wu LY, Lai LY, Song RX, Huang SZ (2012) Clinical research on treatment of migraine with pine needle moxibustion. Zhongguo Zhen Jiu 32:519–522

    PubMed  Google Scholar 

  31. Theodoropoulos DS, Katzenberger DR, Jones WM et al (2011) Allergen-specific sublingual immunotherapy in the treatment of migraines: a prospective study. Eur Rev Med Pharmacol Sci 15:1117–1121

    CAS  PubMed  Google Scholar 

  32. Kurth T, Ridker PM, Buring JE (2008) Migraine and biomarkers of cardiovascular disease in women. Cephalalgia 28:49–56

    CAS  PubMed  Google Scholar 

  33. Gudmundsson LS, Aspelund T, Scher AI et al (2009) C-reactive protein in migraine sufferers similar to that of non-migraineurs: the Reykjavik Study. Cephalalgia 29:1301–1310

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. Loken-Amsrud KI, Myhr KM, Bakke SJ et al (2013) Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis. Mult Scler 19:451–457

    Article  CAS  PubMed  Google Scholar 

  35. Salzer J, Hallmans G, Nyström M, Stenlund H, Wadell G, Sundström P (2013) Vitamin A and systemic inflammation as protective factors in multiple sclerosis. Mult Scler 19:1046–1051

    Article  CAS  PubMed  Google Scholar 

  36. Fragoso YD, Stoney PN, McCaffery PJ (2014) The evidence for a beneficial role of vitamin A in multiple sclerosis. CNS Drugs 28:291–299

    Article  CAS  PubMed  Google Scholar 

  37. Roma E, Krini M, Hantzi E et al (2012) Retinol binding protein 4 in children with inflammatory bowel disease: a negative correlation with the disease activity. Hippokratia 16:360–365

    PubMed Central  CAS  PubMed  Google Scholar 

  38. Brinckerhoff CE, Coffey JW, Sullivan AC (1983) Inflammation and collagenase production in rats with adjuvant arthritis reduced with 13-cis-retinoic acid. Science 221:756–758

    Article  CAS  PubMed  Google Scholar 

  39. Niwa S, Ochi T, Hirano Y et al (2000) Effect of Am-80, a retinoid derivative, on 2, 4-dinitrofluorobenzene-induced contact dermatitis in mice. Pharmacology 60:208–214

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare no financial or other conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Neurology, Bozok University Medical School, 66200, Yozgat, Turkey

    Nermin Tanik, Asuman Celikbilek & Levent Ertugrul Inan

  2. Department of Medical Biology, Bozok University Medical School, Yozgat, Turkey

    Aslı Metin

  3. Department of Biochemistry, Bozok University Medical School, Yozgat, Turkey

    Ayse Yesim Gocmen

Authors
  1. Nermin Tanik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Asuman Celikbilek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aslı Metin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ayse Yesim Gocmen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Levent Ertugrul Inan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nermin Tanik.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tanik, N., Celikbilek, A., Metin, A. et al. Retinol-binding protein-4 and hs-CRP levels in patients with migraine. Neurol Sci 36, 1823–1827 (2015). https://doi.org/10.1007/s10072-015-2262-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-015-2262-6

Keywords

Search

Navigation